← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:551 | 551 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Verapamil Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-2 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2080 | 71286-2080-1 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:551 | 551 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-32 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0429 | 72196-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:551 | 551 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5217 | 26436-5217-1 | Fluticasone Propionate; Hydroquinone; Tretinoin | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9228 | 71266-9228-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:551 | 551 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:551 | 551 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:551 | 551 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:552 | 552 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5537 | 72934-5537-4 | Nobela | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:552 | 552 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diclofenac Sodium; Verapamil Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:552 | 552 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:552 | 552 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2080 | 71286-2080-2 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:552 | 552 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:552 | 552 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:552 | 552 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:552 | 552 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:552 | 552 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:552 | 552 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Foscarnet Sodium | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:552 | 552 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:552 | 552 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:552 | 552 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:552 | 552 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:552 | 552 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:552 | 552 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:553 | 553 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1875 | 73271-1875-1 | TESTOSTERONE 87.5 PEL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dicyclomine Hydrochloride; Aluminum Magnesium Hydroxide Carbonate; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:553 | 553 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-32 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:553 | 553 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-30 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:553 | 553 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:553 | 553 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6440 | 71300-6440-2 | Gabapentin | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:553 | 553 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:553 | 553 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:553 | 553 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:554 | 554 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-003 | 70713-003-01 | TESTOSTERONE C 100MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:554 | 554 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:554 | 554 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:554 | 554 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:554 | 554 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:554 | 554 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:554 | 554 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-09 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:554 | 554 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyaluronic Acid; Ascorbic Acid; Tretinoin | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:554 | 554 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:554 | 554 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8029 | 72196-8029-1 | Glutamic Acid; Aspartic Acid | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:554 | 554 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1014 | 73013-1014-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:554 | 554 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:554 | 554 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:554 | 554 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:554 | 554 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:554 | 554 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:555 | 555 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8050 | 72682-8050-1 | Testosterone 50mg Pellet | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:555 | 555 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:555 | 555 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:555 | 555 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:555 | 555 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-203 | 70004-203-32 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:555 | 555 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:555 | 555 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:555 | 555 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyaluronic Acid; Tretinoin | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:555 | 555 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7009 | 71285-7009-1 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:555 | 555 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8029 | 71285-8029-1 | Glutamic Acid; Aspartic Acid | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:555 | 555 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1019 | 73013-1019-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:555 | 555 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-135 | 82396-135-01 | Heparin Sodium | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:555 | 555 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-141 | 73177-141-27 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:555 | 555 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:555 | 555 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:555 | 555 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:556 | 556 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6638 | 71300-6638-4 | Baclofen | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:556 | 556 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:556 | 556 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:556 | 556 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:556 | 556 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:556 | 556 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:556 | 556 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-32 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:556 | 556 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyaluronic Acid; Tretinoin | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:556 | 556 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7022 | 72196-7022-1 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:556 | 556 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0428 | 71285-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Aspartic Acid; Leucine; Methionine; Proline; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:556 | 556 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1023 | 73013-1023-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:556 | 556 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:556 | 556 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:556 | 556 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:556 | 556 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:556 | 556 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:557 | 557 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-610 | 81375-610-01 | Tirzepatide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:557 | 557 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:557 | 557 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2080 | 71286-2080-2 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:557 | 557 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-40 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:557 | 557 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0402 | 72196-0402-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:557 | 557 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:557 | 557 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:557 | 557 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0600 | 83863-0600-2 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:558 | 558 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-043 | 70713-043-01 | TESTOSTERONE ANASTROZOLE SA2 100MG 4MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:558 | 558 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-2 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:558 | 558 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Hydroquinone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:558 | 558 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:558 | 558 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0413 | 72196-0413-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:558 | 558 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0429 | 72196-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:558 | 558 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:558 | 558 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5055 | 71266-5055-2 | Hydromorphone Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:559 | 559 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Trophamine 3.5% / Dextrose 10% 250ml in 250ml bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:559 | 559 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-7 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:559 | 559 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:559 | 559 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:559 | 559 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-072 | 71449-072-82 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:559 | 559 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Kojic Acid; Hydroquinone; Tretinoin | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0405 | 71285-0405-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:559 | 559 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-686 | 70092-686-48 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-111 | 70092-111-48 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:559 | 559 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6513 | 72934-6513-2 | Hydroquinone | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:560 | 560 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-001 | 81375-001-05 | Cyclosporine Ophthalmic Emulsion | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:560 | 560 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2000 | 71286-2000-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:560 | 560 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:560 | 560 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:560 | 560 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:560 | 560 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Kojic Acid; Hydroquinone; Tretinoin; Azelaic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0405 | 72196-0405-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-4272 | 60652-4272-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-2 | Hydrocortisone; Amphotericin B; Chloramphenicol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-111 | 70092-111-48 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:560 | 560 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6517 | 72934-6517-2 | Hydroquinone | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:561 | 561 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4360 | 72934-4360-9 | Hixdefrima Solution | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:561 | 561 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2080 | 71286-2080-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:561 | 561 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:561 | 561 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:561 | 561 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:561 | 561 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Kojic Acid; Tretinoin; Hydroquinone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0428 | 72196-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:561 | 561 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-1 | Hydrocortisone; Amphotericin B; Chloramphenicol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-28 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-294 | 70092-294-74 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:561 | 561 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6524 | 72934-6524-2 | Hydroquinone | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:562 | 562 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-184 | 71449-184-03 | Lidocaine Hydrochloride, Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:562 | 562 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:562 | 562 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:562 | 562 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:562 | 562 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-2 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:562 | 562 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydrocortisone; Tretinoin; Hydroquinone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8100 | 71285-8100-1 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0420 | 72196-0420-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-504 | 70092-504-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6394 | 72934-6394-2 | Hydrocortisone; Hydroquinone | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:562 | 562 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:562 | 562 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6506 | 72934-6506-2 | Hydroquinone | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:563 | 563 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-3 | m-B12 MIC | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:563 | 563 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2081 | 71286-2081-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:563 | 563 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:563 | 563 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:563 | 563 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 |